Inhibition of JAK1 sensitizes human head and neck cancer cells to cetuximab

被引：0
|
作者：
Bonner, J. A. [1 ]
Trummell, H. [2 ]
Yang, E. [3 ]
机构：
[1] Univ Alabama Birmingham, Radiat Oncol, Birmingham Hosp, Birmingham, AL USA
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] Univ Alabama Birmingham, Birmingham Hosp, Birmingham, AL USA
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
315P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] More on cetuximab in head and neck cancer - Reply
    Bonner, James A.
    Azarnia, Nozar
    Rowinsky, Eric K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21): : 2202 - 2203
  • [22] Lack of cross-resistance to erlotinib in human head and neck cancer cells with acquired resistance to cetuximab
    Bonner, J. A.
    Xing, C.
    Trummell, H.
    ANNALS OF ONCOLOGY, 2023, 34 : S1618 - S1619
  • [23] Cetuximab and Radiation Therapy in Head and Neck Cancer
    Maddalo, Marta
    Triggiani, Luca
    Magrini, Stefano Maria
    Buglione, Michela
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (03): : 678 - 679
  • [24] Cetuximab and the Head and Neck Squamous Cell Cancer
    Concu, Riccardo
    Cordeiro, M. Natalia D. S.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (03) : 192 - 198
  • [25] Cetuximab (Erbitux®) in head and neck cancer, in practice
    Mueller, L.
    Tessen, H. -W
    Goehler, T.
    Doerfef, S.
    Bartels, S.
    Goettel, R.
    ONKOLOGIE, 2010, 33 : 129 - 129
  • [26] Treatment of advanced head and neck cancer with cetuximab
    Merlano, M.
    Garrone, O.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2007, 22 (01): : S71 - S76
  • [27] Low-intensity ultrasound enhances the anticancer activity of cetuximab in human head and neck cancer cells
    Masui, Takashi
    Ota, Ichiro
    Kanno, Masatoshi
    Yane, Katsunari
    Hosoi, Hiroshi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 5 (01) : 11 - 16
  • [28] Cetuximab plus radiotherapy for head and neck cancer
    Cengiz, M
    Yildiz, F
    Genc, M
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (20): : 2187 - 2187
  • [29] Inhibition of JAK1 in human adipocytes ameliorates IFNγ-mediated insulin resistance
    McGillicuddy, Fiona C.
    Chiquoine, Elise H.
    Hinkle, Christine C.
    Reilly, Muredach P.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E35 - E35
  • [30] IFNγ-induced PD-L1 expression is JAK2 but not JAK1 dependent and its inhibition enhances NK-cetuximab mediated ADCC of HNSCC cells
    Concha-Benavente, F.
    Ferris, R. L.
    ORAL ONCOLOGY, 2015, 51 (05) : E33 - E33
12345